0001179110-21-006014.txt : 20210527
0001179110-21-006014.hdr.sgml : 20210527
20210527164656
ACCESSION NUMBER: 0001179110-21-006014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210525
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MINOGUE MICHAEL R
CENTRAL INDEX KEY: 0001286370
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09585
FILM NUMBER: 21973559
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DR
STREET 2: C/O ABIOMED INC
CITY: DANVERS
STATE: MA
ZIP: 01923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABIOMED INC
CENTRAL INDEX KEY: 0000815094
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042743260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 22 CHERRY HILL DR
CITY: DANVERS
STATE: MA
ZIP: 01923
BUSINESS PHONE: 9787775410
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DRIVE
CITY: DANVERS
STATE: MA
ZIP: 01923
4
1
edgar.xml
FORM 4 -
X0306
4
2021-05-25
0
0000815094
ABIOMED INC
ABMD
0001286370
MINOGUE MICHAEL R
C/O ABIOMED, INC.,
22 CHERRY HILL DRIVE
DANVERS
MA
01923
1
1
0
0
Chairman, President, CEO
Common Stock $.01 par value
2021-05-25
4
A
0
8503
0
A
213198
D
Common Stock $.01 par value
52555
I
By Trust - A
Common Stock $.01 par value
73745
I
By Trust - B
Common Stock $.01 par value
32810
I
By Trust - C
Common Stock $.01 par value
655
I
By Trust - D
Common Stock $.01 par value
38560
I
By Trust - E
Common Stock $.01 par value
85040
I
By Trust - F
Stock Option (Right to Buy)
23.15
2014-05-14
2023-05-14
Common stock
0
85000
D
Stock Option (right to buy)
21.55
2015-05-14
2024-05-14
Common Stock
0
85000
D
Stock Option (right to buy)
66.25
2016-05-13
2025-05-13
Common Stock
0
35000
D
Stock Option (right to buy)
99.62
2017-05-24
2026-05-24
Common Stock
0
30500
D
Stock Option (right to buy)
134.51
2018-05-15
2027-05-15
Common Stock
0
33000
D
Stock Option (right to buy)
381.97
2019-05-16
2028-05-16
Common Stock
0
30000
D
Stock Option (right to buy)
266.39
2020-05-30
2029-05-30
Common Stock
0
50000
D
Stock Option (Right to Buy)
223.90
2021-05-29
2030-05-29
Common Stock
0
20898
D
Stock Option (Right to Buy)
283.88
2021-05-25
4
A
0
30000
0
A
2022-05-25
2031-05-25
Common Stock
30000
30000
D
These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25,2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates.
/s/ Ian W. McLeod (by power of attorney)
2021-05-27
EX-24
2
ex24minogue.txt
LIMITED POWER OF ATTORNEY
The undersigned does hereby appoint each of
Stephen McEvoy, Ian McLeod, Michael Dube and Linda Day, signing
singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the
undersigned, in the undersigned's capacity as a
director or officer of ABIOMED, Inc. (the "Company"),
Forms 3, 4 and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934 and the rules
thereunder;
(2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or
desirable to complete and execute any such Form 3, 4
or 5 and timely file such form with the United States
Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever
in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the
undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall
be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-
fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are
not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this power of attorney has
been executed as of the 2nd day of October, 2008 and
shall remain in full force and effect until withdrawn
by the undersigned in writing.
Signature: /s/ Michael R. Minogue
Print Name: Michael R. Minogue